Sales & Marketing News | pharmaphorum

News

ABPI slams UK government consultation on drug levy

For all the UK government’s rhetoric on supporting the life sciences industry, it seems destined to alienate the very sector it is trying to court.

News

New HTA body pledges to ‘cut the hype’ in digital health

US non-profit the Peterson Centre on Healthcare has launched a new institute, backed with $50 million in funding, that will take a close look at the clinical benefits and

News

Beyfortus cleared by FDA for RSV prevention in infants

Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV

News

Big Health buys teen depression DTx developer Limbix

In another example of consolidation in the digital therapeutics (DTx) category, Big Health has agreed to buy Limbix, adding its app for adolescents and young adults with s

News

Haleon nabs rights to Futura’s OTC erectile dysfunction gel

Just over a month after getting FDA approval for the first over-the-counter (OTC) topical therapy for erectile dysfunction (ED), Futura Medical has lined up some heavyweig

News

FTC asks for more info on Pfizer’s $43bn Seagen takeover

The US Federal Trade Commission (FTC) has asked for more information on Pfizer’s $43 billion agreement to acquire Seagen before it will deliver a decision on whether the d

ABPI slams UK government consultation on drug levy

New HTA body pledges to ‘cut the hype’ in digital health

Beyfortus cleared by FDA for RSV prevention in infants

Big Health buys teen depression DTx developer Limbix

Haleon nabs rights to Futura’s OTC erectile dysfunction gel

FTC asks for more info on Pfizer’s $43bn Seagen takeover

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks